title: The efflux inhibitor phenylalanine-arginine beta-naphthylamide (PAβN) permeabilizes the outer membrane of gram-negative bacteria.
abstract: Active efflux of antimicrobial agents is a primary mechanism by which bacterial pathogens can become multidrug resistant. The combined use of efflux pump inhibitors (EPIs) with pump substrates is under exploration to overcome efflux-mediated multidrug resistance. Phenylalanine-arginine β-naphthylamide (PAβN) is a well-studied EPI that is routinely combined with fluoroquinolone antibiotics, but few studies have assessed its utility in combination with β-lactam antibiotics. The initial goal of this study was to assess the efficacy of β-lactams in combination with PAβN against the opportunistic pathogen, Pseudomonas aeruginosa. PAβN reduced the minimal inhibitory concentrations (MICs) of several β-lactam antibiotics against P. aeruginosa; however, the susceptibility changes were not due entirely to efflux inhibition. Upon PAβN treatment, intracellular levels of the chromosomally-encoded AmpC β-lactamase that inactivates β-lactam antibiotics were significantly reduced and AmpC levels in supernatants correspondingly increased, potentially due to permeabilization of the outer membrane. PAβN treatment caused a significant increase in uptake of 8-anilino-1-naphthylenesulfonic acid, a fluorescent hydrophobic probe, and sensitized P. aeruginosa to bulky antibiotics (e.g. vancomycin) that are normally incapable of crossing the outer membrane, as well as to detergent-like bile salts. Supplementation of growth media with magnesium to stabilize the outer membrane increased MICs in the presence of PAβN and restored resistance to vancomycin. Thus, PAβN permeabilizes bacterial membranes in a concentration-dependent manner at levels below those typically used in combination studies, and this additional mode of action should be considered when using PAβN as a control for efflux studies.
authors.affiliation: Department of Biochemistry and Biomedical Sciences, Michael G. DeGroote Institute for Infectious Disease Research, McMaster University, Hamilton, Ontario, Canada.
authors.forename: Ryan P
authors.initials: RP
authors.lastname: Lamers
authors.forename: Joseph F
authors.initials: JF
authors.lastname: Cavallari
authors.forename: Lori L
authors.initials: LL
authors.lastname: Burrows
mesh_terms: D000817:Anilino Naphthalenesulfonates / Q000378:metabolism; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D001426:Bacterial Proteins / Q000378:metabolism; D002463:Cell Membrane Permeability / Q000187:drug effects*; D003470:Culture Media; D003902:Detergents / Q000494:pharmacology; D004151:Dipeptides / Q000494:pharmacology*; D024881:Drug Resistance, Bacterial / Q000187:drug effects; D006090:Gram-Negative Bacteria / Q000166:cytology* / Q000187:drug effects*; D008274:Magnesium / Q000494:pharmacology; D008826:Microbial Sensitivity Tests; D019897:Periplasm / Q000187:drug effects / Q000378:metabolism; D011550:Pseudomonas aeruginosa / Q000187:drug effects; D001618:beta-Lactamases / Q000378:metabolism; D047090:beta-Lactams / Q000494:pharmacology
chemical_list: D000817:Anilino Naphthalenesulfonates; D000900:Anti-Bacterial Agents; D001426:Bacterial Proteins; D003470:Culture Media; D003902:Detergents; D004151:Dipeptides; D047090:beta-Lactams; C419365:phenylalanine arginine beta-naphthylamide; C027132:1-anilino-8-naphthalenesulfonate; C048795:AmpC beta-lactamases; D001618:beta-Lactamases; D008274:Magnesium
references.citation: Antimicrob Agents Chemother. 2000 Dec;44(12):3317-21
references.pmid: 11083634
references.citation: J Antimicrob Chemother. 2005 Jul;56(1):20-51
references.pmid: 15914491
references.citation: J Antimicrob Chemother. 2003 Jan;51(1):9-11
references.pmid: 12493781
references.citation: Antimicrob Agents Chemother. 1995 Sep;39(9):1948-53
references.pmid: 8540696
references.citation: Recent Pat Antiinfect Drug Discov. 2009 Jan;4(1):37-50
references.pmid: 19149695
references.citation: Nature. 2000 Aug 31;406(6799):959-64
references.pmid: 10984043
references.citation: Biochem Pharmacol. 2006 Mar 30;71(7):910-8
references.pmid: 16427026
references.citation: Antimicrob Agents Chemother. 2001 Jan;45(1):105-16
references.pmid: 11120952
references.citation: J Antimicrob Chemother. 2007 Jun;59(6):1223-9
references.pmid: 17229832
references.citation: Drug Resist Updat. 1998;1(2):93-8
references.pmid: 16904394
references.citation: Clin Microbiol Rev. 2006 Apr;19(2):382-402
references.pmid: 16614254
references.citation: J Mol Microbiol Biotechnol. 2001 Apr;3(2):255-64
references.pmid: 11321581
references.citation: EMBO J. 1994 Oct 3;13(19):4684-94
references.pmid: 7925310
references.citation: J Bacteriol. 2011 Sep;193(17):4509-15
references.pmid: 21725004
references.citation: J Bacteriol. 2005 Oct;187(19):6804-15
references.pmid: 16166543
references.citation: J Antimicrob Chemother. 2007 Dec;60(6):1206-15
references.pmid: 17878146
references.citation: PLoS Pathog. 2009 Mar;5(3):e1000353
references.pmid: 19325877
references.citation: Anal Sci. 2003 Sep;19(9):1239-42
references.pmid: 14516073
references.citation: PLoS One. 2011 Apr 12;6(4):e18547
references.pmid: 21533264
references.citation: Trends Mol Med. 2005 Aug;11(8):382-9
references.pmid: 15996519
references.citation: Nat Rev Microbiol. 2006 Aug;4(8):629-36
references.pmid: 16845433
references.citation: J Mol Microbiol Biotechnol. 2001 Apr;3(2):225-36
references.pmid: 11321578
references.citation: J Med Chem. 1999 Dec 2;42(24):4928-31
references.pmid: 10585202
references.citation: Antimicrob Agents Chemother. 2012 Aug;56(8):4131-9
references.pmid: 22615276
references.citation: Microbiol Mol Biol Rev. 2003 Dec;67(4):593-656
references.pmid: 14665678
references.citation: J Antimicrob Chemother. 1999 Oct;44(4):537-40
references.pmid: 10588316
references.citation: J Antimicrob Chemother. 2000 Apr;45(4):433-6
references.pmid: 10747818
references.citation: Antimicrob Agents Chemother. 2011 Oct;55(10):4560-8
references.pmid: 21807976
references.citation: Libyan J Med. 2011 May 13;6:
references.pmid: 21594004
references.citation: Antimicrob Agents Chemother. 2012 Jan;56(1):231-42
references.pmid: 22005996
references.citation: Future Microbiol. 2011 Dec;6(12):1415-27
references.pmid: 22122439
references.citation: Biochemistry. 2010 Sep 21;49(37):8094-104
references.pmid: 20726582
references.citation: J Bacteriol. 1997 Apr;179(8):2512-8
references.pmid: 9098046
references.citation: Protein Sci. 2001 Jun;10(6):1254-9
references.pmid: 11369864
references.citation: Antimicrob Agents Chemother. 1984 Oct;26(4):546-51
references.pmid: 6440475
references.citation: Gene. 1998 May 28;212(1):77-86
references.pmid: 9661666
references.citation: J Proteome Res. 2010 Jun 4;9(6):2957-67
references.pmid: 20373734
references.citation: Expert Opin Drug Discov. 2012 Jul;7(7):633-42
references.pmid: 22607346
references.citation: Clin Microbiol Rev. 2009 Oct;22(4):582-610
references.pmid: 19822890